28 recruiting, 19 not yet recruiting, 8 completed, 6 active not recruiting. 14 Not applicable, 12 Phase 1, 11 Phase 2, 4 Early Phase 1, 3 Phase 3.
Follow Gastric Cancer (GC): new trials by email Literature Review of Gastric Cancer (GC) trials Research Report on Gastric Cancer (GC)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IKS04 Regimen in Advanced Solid Tumors That Express CA242 IKS04 antibody drug conjugate ADC + Isumab04 monoclonal antibody - Colorectal Cancer, Gastro Esophageal Junctional Cancer | Phase 1 | Not yet recruiting | Iksuda Therapeutics Ltd. | 120 | 2026-11-01 | 2026-07-31 |
| Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) Stereotactic Body Radiation Therapy (SBRT), Pembrolizumab, Nivolumab - Head and Neck Cancer, Non-Small Cell Lung Cancer | Phase 2 | Recruiting | Mark Bernard | 35 | 2026-09-09 | 2026-10-14 |
| A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors TS-104 - NSCLC (Non-small Cell Lung Cancer), HNSCC | Phase 1 | Recruiting | TwoStep Therapeutics, Inc. | 74 | 2026-09-02 | 2026-09-30 |
| A Study of MGC030 in Participants With Advanced Solid Tumors MGC030 - Urothelial Cancer, GastroEsophageal Cancer | Phase 1 | Not yet recruiting | MacroGenics | 314 | 2026-09-01 | 2026-09-16 |
| A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection Combined With Immune Checkpoint Inhibitors for Metastatic Tumors (Colorectal Cancer, Gastric Cancer, and Hepatocellular Carcinoma) Colorectal Cancer (CRC), Gastric Cancer (GC) | Recruiting | Jie Yuan，MD | 30 | 2026-09-01 | 2026-09-30 | |
| Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer [64Cu]CM500, [68Ga]CM500, PET/MR - Bladder Cancer, Glioma | Early Phase 1 | Not yet recruiting | Lumina Pharmaceuticals Inc | 40 | 2026-09-01 | 2026-08-28 |
| SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors SKL35501, SKL35502 - Selected Advanced Solid Tumors, Colorectal Cancer (CRC) | Phase 1 | Recruiting | SK Life Science, Inc. | 100 | 2026-08-19 | 2026-09-10 |
| FAPI PET Imaging - An Exploratory Study [18F]FAPI-74 PET/CT - Thyroid Pathology, Head and Neck Cancer (H&N) | Phase 1 / Phase 2 | Not yet recruiting | Martin Huellner | 770 | 2026-08-01 | 2026-07-15 |
| Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric Cancer Ferric Carboxymaltose (FCM), Iron Sucrose. - Gastric Cancer (GC), Iron Deficiency Anemia (IDA) | Phase 4 | Not yet recruiting | Zhaojian Niu,MD | 160 | 2026-08-01 | 2026-08-19 |
| TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial) Transcutaneous Electrical Acupoint Stimulation, Sham Transcutaneous Electrical Acupoint Stimulation - Gastric Cancer (GC), Stomach Neoplasms | Not applicable | Recruiting | The Affiliated Hospital of Qingdao University | 300 | 2026-07-25 | 2026-10-16 |
| Developing and Testing the Effectiveness of Smart Healthcare Assisted Individualized Symptom Management Education and Home-based Exercise on Frailty, Treatment-related Adverse Events and Quality of Life in Advanced Gastric Cancer Patients Receiving Immunotherapy AI-ISME&HE - Gastric Cancer (GC), Immunotherapy | Not applicable | Not yet recruiting | Taipei Veterans General Hospital, Taiwan | 110 | 2026-07-21 | 2026-07-29 |
| Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites Gastric Cancer Peritoneal Metastases, Gastric Cancer (GC) | Recruiting | Zhejiang Cancer Hospital | 50 | 2026-07-01 | 2026-10-02 | |
| Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer COPOX, Radiotherapy, SHR-1701 - Gastric Cancer (GC), Gastroesophageal Junction Adenocarcinoma | Phase 2 | Recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 60 | 2026-07-01 | 2026-07-08 |
| Multimodal Prehabilitation in Gastric Cancer Patients prehabilitation - Gastric Cancer (GC), Prehabilitation | Not applicable | Recruiting | National University Hospital, Singapore | 25 | 2026-07-01 | 2026-09-24 |
| [68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications [68Ga]BED003 - Colorectal Cancer, Epithelial Ovarian Cancer | Phase 2 | Recruiting | Blue Earth Diagnostics | 71 | 2026-06-30 | 2026-09-15 |
| Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNA Gastric Cancer (GC), Pancreatic Cancer | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 300 | 2026-06-01 | 2026-05-08 | |
| Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant Ascites Retlirafusp Alfa + SOX + Intraperitoneal Nab-Paclitaxel - Gastric Cancer (GC), Peritoneal Metastases From Gastric Cancer | Not applicable | Active not recruiting | Zhejiang Cancer Hospital | 5 | 2026-06-01 | 2026-10-02 |
| A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma Iparomlimab and Tuvonralimab (QL1706) - Gastric Cancer (Diagnosis), Gastric Cancer (GC) | Phase 4 | Not yet recruiting | Huazhong University of Science and Technology | 55 | 2026-06-01 | 2026-03-30 |
| A Study on the Efficacy of Sodium Propionate Combined With Anti-PD-1 Immunotherapy in Gastric Cancer Sodium propionate - Gastric Cancer (GC) | Not applicable | Not yet recruiting | Jinling Hospital, China | 20 | 2026-05-30 | 2026-05-29 |
| AI-Based Risk Prediction Model for Upper Digestive Tract Cancer Gastric Cancer (GC), Premalignant Lesion | Not yet recruiting | National Taiwan University Hospital | 10000 | 2026-05-18 | 2026-05-28 |
Showing 20 of 68. Sign in to see all of them.
Stomach Neoplasms (68) · Colorectal Neoplasms (16) · Esophageal Neoplasms (9) · Carcinoma, Non-Small-Cell Lung (6) · Pancreatic Neoplasms (6) · Breast Neoplasms (5) · Biliary Tract Neoplasms (4) · Carcinoma, Hepatocellular (4) · Gastrointestinal Neoplasms (4) · Neoplasms (4) · Carcinoma, Transitional Cell (3) · Cholangiocarcinoma (3) · Disease (3) · Head and Neck Neoplasms (3) · Liver Neoplasms (3)
Digestive System Diseases (68) · Neoplasms by Site (68) · Gastrointestinal Diseases (67) · Stomach Diseases (67) · Digestive System Neoplasms (66) · Gastrointestinal Neoplasms (64) · Neoplasms (64) · Colonic Diseases (16) · Intestinal Diseases (16) · Intestinal Neoplasms (16) · Rectal Diseases (16) · Pathological Conditions, Signs and Symptoms (14) · Pathologic Processes (12) · Esophageal Diseases (11) · Neoplasms by Histologic Type (11)
Oxaliplatin (4) · Bevacizumab (3) · Fluorodeoxyglucose F18 (2) · Radiotherapy (2) · S 1 (combination) (2) · SHR-1701 (2) · pembrolizumab (2) · Angptl4 protein, mouse (1) · Blood Specimen Collection (1) · Capecitabine (1) · Carboplatin (1) · Cisplatin (1) · Clinical Protocols (1) · Dietary Supplements (1) · Docetaxel (1)
Beijing Friendship Hospital (3) · Qilu Hospital of Shandong University (3) · Affiliated Hospital of Jiangnan University (2) · Fudan University (2) · P. Herzen Moscow Oncology Research Institute (2) · Ruijin Hospital (2) · The Affiliated Hospital of Qingdao University (2) · The First Affiliated Hospital with Nanjing Medical University (2) · Tianjin Medical University Cancer Institute and Hospital (2) · Zhejiang Cancer Hospital (2) · Ankara Etlik City Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · Base Therapeutics (Shanghai) Co., Ltd. (1) · Blue Earth Diagnostics (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)
China (32) · United States (8) · Russia (3) · South Korea (3) · Italy (2) · Turkey (Türkiye) (2) · Australia (1) · Belgium (1) · Germany (1) · Netherlands (1) · Portugal (1) · Singapore (1) · Spain (1) · Switzerland (1) · Ukraine (1)
Andrey Ryabov, MD, PhD (2) · Vladimir Khomyakov, MD, PhD (2) · Ajay Goel, PhD (1) · Bin Wang (1) · Frank Perabo, MD, PhD (1) · Galip Can Uyar, MD (1) · Gennaro Daniele (1) · I-Wen Chang, PhD (1) · James O'Leary, MD (1) · Jieer Ying, Dr (1) · Jing Jin, M.D. (1) · Nadezhda Volchenko, MD, PhD (1) · Nuriddin Abdulkhakimov, PhD (1)
PMID 23667204, PMID 32060757, PMID 33538338, PMID 33663942, PMID 37072637, PMID 39566200, PMID 39580964, PMID 40676300, PMID 40898955, PMID 40960020, PMID 41196468, PMID 41399049, PMID 42623594, PMID 42830480
2023 (1), 2025 (1), R44CA275590 (1)